InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（14 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
14
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by McNeill Jonathan, 管理人员. Director active across 2 companies, notably Dyne Therapeutics, Inc.. Aggregated, 25 reports have been published. Breakdown: 0 buy · 14 sells. Total volume traded: €807k. Activity tracked since 20 September 2021. The latest transaction was filed on 19 August 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to McNeill Jonathan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报25 总计
20,549 股Ordinary SharesSEC:0001628280-26-044885:0
19,507 股Ordinary SharesSEC:0001628280-25-057678:0
2,400 股@ US$45.017.5% 占其流量Common StockSEC:0000950170-24-099127:0
1,823 股@ US$31.344.1% 占其流量Common StockSEC:0000950170-24-072151:0
2,279 股@ US$28.204.5% 占其流量Common StockSEC:0000950170-24-062075:0
86,159 股@ US$5.5433.5% 占其流量Common StockSEC:0000950170-24-030484:0
2,434 股@ US$25.854.4% 占其流量Common StockSEC:0000950170-24-029607:0
4,268 股@ US$0.730.2% 占其流量Common StockSEC:0000950170-24-024299:0
20,000 股@ US$0.731.0% 占其流量Common StockSEC:0000950170-24-008062:0
11,900 股@ US$13.1010.9% 占其流量Common StockSEC:0000950170-24-002278:0
1,245 股@ US$10.721.0% 占其流量Common StockSEC:0001209191-23-058330:0
96,158 股0Common StockSEC:0001209191-23-055530:0
1,261 股@ US$9.412.6% 占其流量Common StockSEC:0001209191-23-050173:0
1,266 股@ US$10.410.9% 占其流量Common StockSEC:0001209191-23-049360:0
1,000 股@ US$13.000.9% 占其流量Common StockSEC:0001209191-23-037167:0
1,000 股@ US$13.000.9% 占其流量Common StockSEC:0001209191-23-018981:0
10,000 股@ US$0.730.5% 占其流量Common StockSEC:0001209191-23-004345:0
30,150 股@ US$11.5725.2% 占其流量Common StockSEC:0001209191-23-003013:0
40,000 股0Common StockSEC:0001209191-22-060972:0
1,246 股@ US$13.701.3% 占其流量Common StockSEC:0001209191-22-050891:0
494 股@ US$14.050.5% 占其流量Common StockSEC:0001209191-22-050122:0
504 股@ US$4.950.2% 占其流量Common StockSEC:0001209191-22-037150:0
481 股@ US$8.730.3% 占其流量Common StockSEC:0001209191-22-018536:0
25,311 股0Common StockSEC:0001209191-21-069425:0
545 股@ US$15.610.6% 占其流量Common StockSEC:0001209191-21-057325:0
25 条申报中的 25 条
About McNeill Jonathan
McNeill Jonathan is an executive, with 25 filings in total. The 25 filings in the recent sample run from 2021-09-22 to 2026-06-23, and the disposals observed in that recent sample total 833587 EUR, with no purchases reported. His listed companies are Dyne Therapeutics, Inc., where he is Chief Business Officer, and CRESCENT BIOPHARMA, INC., where he is President and COO.
